Objective To study the clinical characteristics of children with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Methods A retrospective analysis was conducted on the clinical data of 25 children diagnosed with AAV at the Second Xiangya Hospital of Central South University from January 2010 to June 2022. Results Among the AAV children, there were 5 males and 20 females, with a median age of onset of 11.0 years. Involvement of the urinary system was seen in 18 cases (72%); respiratory system involvement in 10 cases (40%); skin involvement in 6 cases (24%); eye, ear, and nose involvement in 5 cases (20%); joint involvement in 4 cases (16%); digestive system involvement in 2 cases (8%). Eleven cases underwent kidney biopsy, with 5 cases (46%) showing focal type, 2 cases (18%) showing crescentic type, 2 cases (18%) showing mixed type, and 2 cases (18%) showing sclerotic type. Immune complex deposits were present in 5 cases (45%). Seven cases reached chronic kidney disease (CKD) stage V, with 2 cases resulting in death. Two cases underwent kidney transplantation. At the end of the follow-up period, 2 cases were at CKD stage II, and 1 case was at CKD stage III. Of the 16 cases of microscopic polyangiitis (MPA) group, 13 (81%) involved the urinary system. Of the 9 cases of granulomatosis with polyangiitis (GPA), 6 cases (66%) had sinusitis. Serum creatinine and uric acid levels were higher in the MPA group than in the GPA group (P<0.05), while red blood cell count and glomerular filtration rate were lower in the MPA group (P<0.05). Conclusions AAV is more common in school-age female children, with MPA being the most common clinical subtype. The onset of AAV in children is mainly characterized by renal involvement, followed by respiratory system involvement. The renal pathology often presents as focal type with possible immune complex deposits. Children with MPA often have renal involvement, while those with GPA commonly have sinusitis. The prognosis of children with AAV is poor, often accompanied by renal insufficiency.
Key words
Anti-neutrophil cytoplasmic antibody-associated vasculitis /
Clinical manifestation /
Chronic kidney disease /
Prognosis /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
1 Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. PMID: 23045170. DOI: 10.1002/art.37715.
2 Jariwala M, Laxer RM. Childhood GPA, EGPA, and MPA[J]. Clin Immunol, 2020, 211: 108325. PMID: 31837445. DOI: 10.1016/j.clim.2019.108325.
3 Watts RA, Mahr A, Mohammad AJ, et al. Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis[J]. Nephrol Dial Transplant, 2015, 30 (Suppl 1): i14-i22. PMID: 25805746. DOI: 10.1093/ndt/gfv022.
4 吴小川, 许丽云. 儿童风湿病国际相关诊治指南系列解读之六——儿童抗中性粒细胞胞浆抗体相关性血管炎分类标准解读[J]. 中国实用儿科杂志, 2020, 35(4): 265-268. DOI: 10.19538/j.ek2020040606.
5 Berden AE, Ferrario F, Hagen EC, et al. Histopathologic classification of ANCA-associated glomerulonephritis[J]. J Am Soc Nephrol, 2010, 21(10): 1628-1636. PMID: 20616173. DOI: 10.1681/ASN.2010050477.
6 林梦婕, 白培进, 陈仕智, 等. 老年抗中性粒细胞胞质抗体相关性血管炎合并肾脏免疫复合物沉积的临床与病理特点分析[J]. 中国全科医学, 2020, 23(23): 2908-2912. DOI: 10.12114/j.issn.1007-9572.2020.00.212.
7 Schwartz GJ, Mu?oz A, Schneider MF, et al. New equations to estimate GFR in children with CKD[J]. J Am Soc Nephrol, 2009, 20(3): 629-637. PMID: 19158356. PMCID: PMC2653687. DOI: 10.1681/ASN.2008030287.
8 赵三龙, 吴红梅, 赵非, 等. 儿童抗中性粒细胞胞质抗体相关性血管炎13例临床分析[J]. 中华肾脏病杂志, 2022, 38(8): 664-671. DOI: 10.3760/cma.j.cn441217-20220315-00095.
9 张沛, 吴和燕, 高春林, 等. 儿童抗中性粒细胞胞质抗体相关性血管炎的临床分析[J]. 中华肾脏病杂志, 2020, 36(7): 550-553. DOI: 10.3760/cma.j.cn441217-20191023-00100.
10 Akikusa JD, Schneider R, Harvey EA, et al. Clinical features and outcome of pediatric Wegener's granulomatosis[J]. Arthritis Rheum, 2007, 57(5): 837-844. PMID: 17530684. DOI: 10.1002/art.22774.
11 Iudici M, Quartier P, Terrier B, et al. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis[J]. Orphanet J Rare Dis, 2016, 11(1): 141. PMID: 27770813. PMCID: PMC5075395. DOI: 10.1186/s13023-016-0523-y.
12 Calatroni M, Oliva E, Gianfreda D, et al. ANCA-associated vasculitis in childhood: recent advances[J]. Ital J Pediatr, 2017, 43(1): 46. PMID: 28476172. PMCID: PMC5420084. DOI: 10.1186/s13052-017-0364-x.
13 Tanna A, Pusey CD. The histopathological classification of ANCA-associated glomerulonephritis comes of age[J]. J Rheumatol, 2017, 44(3): 265-267. PMID: 28250161. DOI: 10.3899/jrheum.170006.
14 Quintana LF, Peréz NS, De Sousa E, et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis[J]. Nephrol Dial Transplant, 2014, 29(9): 1764-1769. PMID: 24748668. DOI: 10.1093/ndt/gfu084.
15 Domingues VM, Machado B, Santos J. ANCA-positive vasculitis: clinical implications of ANCA types and titers[J]. Rev Assoc Med Bras (1992), 2016, 62(5): 434-440. PMID: 27656853. DOI: 10.1590/1806-9282.62.05.434.
16 Wallace ZS, Stone JH. Personalized medicine in ANCA-associated vasculitis ANCA specificity as the guide?[J]. Front Immunol, 2019, 10: 2855. PMID: 31867013. PMCID: PMC6909331. DOI: 10.3389/fimmu.2019.02855.
17 Morris A, Geetha D. PEXIVAS challenges current ANCA-associated vasculitis therapy[J]. Nat Rev Nephrol, 2020, 16(7): 373-374. PMID: 32203311. DOI: 10.1038/s41581-020-0269-6.
18 Correction: EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2022, 81(6): e109. PMID: 35577366. DOI: 10.1136/annrheumdis-2016-209133corr2.
19 Sacri AS, Chambaraud T, Ranchin B, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: a French nationwide study[J]. Nephrol Dial Transplant, 2015, 30 (Suppl 1): i104-i112. PMID: 25676121. DOI: 10.1093/ndt/gfv011.
PDF(534 KB)
